Yüksel Ürün on CheckMate 901 trial

Yüksel Ürün shared a post on X:

“CheckMate 901 trial: Abstract #4509

For lymph node-only mUC, NIVO+GC resulted in durable disease control and significant OS and PFS improvements. Proud to have played a role in this impactful study.”

Source: Yüksel Ürün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.